Cairn Investment Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
1,060
+170
+19% +$39.6K 0.12% 64
2026
Q1
$218K Buy
+890
New +$207K 0.11% 62
2023
Q3
Sell
-1,271
Closed -$211K 63
2023
Q2
$211K Sell
1,271
-284
-18% -$45.8K 0.14% 63
2023
Q1
$241K Sell
1,555
-259
-14% -$41.8K 0.17% 59
2022
Q4
$320K Buy
1,814
+102
+6% +$17.6K 0.24% 56
2022
Q3
$280K Hold
1,712
0.23% 62
2022
Q2
$304K Buy
+1,712
New +$305K 0.24% 65
2021
Q2
Sell
-1,630
Closed -$268K 74
2021
Q1
$268K Buy
1,630
+130
+9% +$21K 0.22% 68
2020
Q4
$236K Buy
+1,500
New +$221K 0.22% 68
2020
Q3
Sell
-210,945
Closed -$1.5M 73
2020
Q2
$1.5M Buy
+210,945
New +$30.7M 1.82% 21
2020
Q1
Sell
-1,500
Closed -$218K 79
2019
Q4
$218K Buy
+1,500
New +$203K 0.22% 83

Other funds holding JNJ

Cairn Investment Group's JNJ Position: Q2 2026 in Review

Cairn Investment Group increased its Johnson & Johnson (JNJ) stake by 19% in Q2 2026, buying an estimated $39.6K and bringing the position to 1,060 shares worth $269K. The position accounts for 0.12% of the portfolio, ranked #64.

Cairn Investment Group first reported a position in JNJ in Q4 2019 and has held it in 11 quarters since. The position peaked at $1.5M in Q2 2020. 4,682 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cairn Investment Group held 1,060 shares of Johnson & Johnson worth $269K as of Q2 2026.
  • Cairn Investment Group bought 170 Johnson & Johnson shares in Q2 2026, an estimated $39.6K.
  • Johnson & Johnson made up 0.12% of Cairn Investment Group's portfolio in Q2 2026, its #64 holding.
  • Cairn Investment Group first reported a position in Johnson & Johnson in Q4 2019 and has held it in 11 quarters since.
  • Cairn Investment Group's Johnson & Johnson position peaked at $1.5M in Q2 2020.
  • 4,682 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cairn Investment Group's 13F filing for Q2 2026, filed 28 Jul 2026.